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ABSTRACT
The relationship between distribution of urologists and mortality of bladder 
and prostate cancers has not been clearly established. The aim of this study was to 
investigate the relationship between uneven distribution of urologists and urologic 
cancer specific mortality at country level. Data from the National Health Insurance 
Service and National Statistical Office in Korea from 2007 to 2011 were analyzed 
in this ecological study. Univariate and multivariable regression analyses were 
performed to determine risk factors for age standardized mortality rates (ASMR) of 
bladder and prostate cancers. Linear regression analysis showed a markedly (p < 
0.001) uneven distribution of urologists between metropolitan and non-metropolitan 
areas. There was no significant difference in cancer specific ASMRs for either bladder 
cancer or prostate cancer. Univariate analysis after adjusting for time showed that 
country area, urologist density, and income were significant factors affecting bladder 
cancer incidence (p < 0.001, p = 0.013, and p < 0.001, respectively). It also showed 
that the number of training hospitals was a significant factor for prostate cancer 
incidence (p = 0.002). Although country area showed borderline significance (p = 
0.056) for ASMR of bladder cancer, urologist density was not related to ASMR of 
bladder cancer or prostate cancer. Although there was a marked difference in urologist 
density between metropolitan and non-metropolitan areas for these years analyzed, 
mortality rates of bladder and prostate cancers were not significantly affected by 
country area or urologist density. 
INTRODUCTION
Although there have been great developments 
in medical services, uneven geographic distribution 
of clinicians is becoming one critical problem in the 
perspective of community health [1]. An uneven distribution 
of physicians in rural areas has been generally recognized 
[2] to be associated not only with treatment of common 
diseases, but also with treatment of specific cancers [3]. 
Physicians can be categorized to two types 
according to their expected roles: primary care physicians 
and specialists. It has been reported that mortalities from 
cancers, including urological cancers and gastrointestinal 
tract cancers, are affected by an uneven density of 
urologists and general surgeons [4–6].
 Recently, Odisho et al. [6] have performed a national 
ecological study and reported that mortality rates of kidney, 
bladder, and prostate cancers in rural areas are affected 
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by urologist density. However, there are conflicting data 
about this issue [7, 8]. Other reports have indicated that 
urologist density is not directly correlated with improved 
mortality rates [9, 10]. This phenomenon is related to the 
so-called “plateau phenomenon”, which reported not only 
for urological cancers, but also for other cancers [11].
The uneven distribution of physicians, including 
urologists, could be more significant because aging is 
progressing rapidly in the society. In a generally aging 
society, aging of physicians are also expected. Moreover, 
South Korea is one of several countries with an extremely 
rapid rate of aging. An uneven distribution of primary 
physicians and urologists for these years analyzed in this 
study has been documented in our previous study [12]. 
The aim of this study was to determine the impact 
of types of country areas, including metropolitan area 
and rural area, and urologist density after adjustment for 
years on bladder cancer and prostate cancer incidence and 
mortality. Although many studies about this issue have 
been reported in the US, this is the first study on this issue 
in Asia. Due to the aging society, public health policy has 
to be schemed with limited budget in the future. Therefore, 
it is important to emphasize cost-effectiveness when 
treating diseases besides proper density and distribution 
of doctors. Results of this study could provide useful 
information to prepare proper strategy for future policies 
in public health. 
RESULTS
Basic characteristics
Basic characteristics of two county units 
(metropolitan area and non-metropolitan area) are shown 
in Table 1. ASMR1 and ASMR2 showed no significant 
differences between metropolitan area and non-metropolitan 
area. Incidence of bladder cancer in non-metropolitan area 
was significantly higher than that in metropolitan area in 
2007 and 2008 (p = 0.032 and p = 0.005, respectively). 
Incidence of prostate cancer in non-metropolitan area was 
also significantly higher than that in metropolitan area in 
2007 and 2009 (p = 0.035 and p = 0.036, respectively).  
Annual change of doctor density and urologist 
density 
 Annual changes of doctor density and urologist 
density in metropolitan and non-metropolitan areas are 
shown in Table 2 and Figure 1. Both doctor density and 
urologist density showed were higher in metropolitan areas 
compared to non-metropolitan areas (both p < 0.001). 
However, after adjusting years with reference year of 
2007, only urologist density was higher in metropolitan 
area compared to that in non-metropolitan area (p = 0.002).
Trends of incidence and mortality of bladder 
cancer and prostate cancer
Trends of incidence, ASMR1 and ASMR2, for the 
period of 2007 to 2011 are shown in Table 3. The incidence 
of bladder cancer showed no significantly increasing 
pattern in either metropolitan area or non-metropolitan 
area (p = 0.182 and p = 0.378, respectively). However, 
mortality of bladder cancer showed significantly increasing 
pattern in both metropolitan and non-metropolitan areas 
(p = 0.006 and p = 0.001, respectively). For bladder 
cancer, ASMR1 showed significantly increasing trend in 
both metropolitan and non-metropolitan areas (p = 0.028 
and p = 0.003, respectively). However, ASMR2 showed 
significantly increasing pattern only in non-metropolitan 
area (p = 0.001). Estimates of ASMR1 and ASMR2 
in non-metropolitan area were higher than those in 
metropolitan area. For prostate cancer, both ASMR1 and 
ASMR2 showed no significant increase in metropolitan 
Figure 1: Annual changes of doctor density and urologist density according to years.
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Table 1: Basic characteristics of metropolitan and non-metropolitan areas
Bladder cancer Prostate cancer
Metropolitan Non-metropolitan p-value
† Metropolitan Non-metropolitan p-value
ASMR1
2007 2.1 1.9 0.498 2.3 2.1 0.611
2008 2.2 1.9 0.429 2.5 2.3 0.490
2009 2.0 1.8 0.250 2.8 2.4 0.205
2010 2.0 2.2 0.242 2.7 2.6 0.565
2011 2.3 2.3 0.776 2.8 2.7 0.371
ASMR2
2007 3.2 2.9 0.339 4.7 4.3 0.539
2008 3.3 2.9 0.390 5.0 4.5 0.459
2009 3.1 2.7 0.243 5.7 4.8 0.210
2010 3.0 3.4 0.225 5.6 5.5 0.706
2011 3.4 3.5 0.862 5.8 5.5 0.547
Incidence
2007 5.7 7.2 0.032 18.1 24.4 0.035
2008 5.8 7.5 0.005 22.2 29.0 0.064
2009 6.1 7.2 0.068 25.4 33.5 0.036
2010 6.4 7.4 0.152 26.8 35.4 0.050
2011 6.3 7.8 0.096 81.1 92.8 0.774
Doctor density
2007 159.5 120.3 0.021 159.5 120.3 0.021
2008 166.6 127.7 0.035 166.6 127.7 0.035
2009 173.2 133.1 0.036 173.2 133.1 0.036
2010 170.2 130.8 0.045 170.2 130.8 0.045
2011 170.2 130.8 0.045 170.2 130.8 0.045
Urologist 
density
2007 4.1 3.1 0.007 4.1 3.1 0.007
2008 4.1 3.3 0.019 4.1 3.3 0.019
2009 4.4 3.4 0.013 4.4 3.4 0.013
2010 4.5 3.5 0.011 4.5 3.5 0.011
2011 4.6 3.6 0.020 4.6 3.6 0.020
No. of 
training 
hospital
2007 7.9 3.7 0.370 7.9 3.7 0.370
2008 7.9 3.7 0.370 7.9 3.7 0.370
2009 7.9 3.7 0.370 7.9 3.7 0.370
2010 7.9 3.7 0.370 7.9 3.7 0.370
2011 7.9 3.7 0.370 7.9 3.7 0.370
Income
2007 12193.1 10811.2 0.087 12193.1 10811.2 0.087
2008 12730.1 11378.4 0.094 12730.1 11378.4 0.094
2009 13173.3 12028.3 0.129 13173.3 12028.3 0.129
2010 13915.9 12300.0 0.042 13915.9 12300.0 0.042
2011 15033.0 13185.0 0.040 15033.0 13185.0 0.040
Temp
2007 14.2 13.3 0.153 14.2 13.3 0.153
2008 13.9 13.0 0.147 13.9 13.0 0.147
2009 13.9 13.0 0.176 13.9 13.0 0.176
2010 13.5 12.6 0.192 13.5 12.6 0.192
2011 13.3 12.4 0.203 13.3 12.4 0.203
P value by t-test.
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areas. However, in non-metropolitan areas, both ASMR1 
and ASMR2 showed significantly increasing patterns 
(p = 0.014 and p = 0.009, respectively).
Univariate analysis for cancer incidence, 
ASMR1, and ASMR2
Univariate analysis after adjusting for time showed 
that geographic area, urologist density, and income were 
significant factors affecting bladder cancer incidence 
(p < 0.001, p = 0.013, and p < 0.001, respectively). It 
also showed that the number of training hospitals was a 
significant factor for prostate cancer incidence (p = 0.002) 
(Table 4). Temperature was the only significant factor 
affecting ASMR of bladder cancer, although geographic 
area showed a borderline significance for ASMR1 and 
ASMR2 of bladder cancer (p = 0.056 and p = 0.060, 
respectively). Doctor density and urologist density showed 
no significant correlation with either ASMR1 or ASMR2 
(Figures 2 and 3).
Multivariable analysis for bladder cancer 
incidence 
Since there was no significant factor for ASMR, 
a multivariable analysis was conducted only for 
bladder cancer incidence. Results are shown in Table 5. 
Geographic area was the only significant factor for bladder 
cancer incidence, with a higher (p = 0.001) incidence in 
non-metropolitan area compared to that in metropolitan 
area. For prostate cancer, training hospital was the only 
significant factor for its incidence (p = 0.005).
DISCUSSION
Establishing an adequate doctor workforce and 
its proper distribution is becoming an issue of great 
importance considering the increasing demand for cancer 
care [13, 14]. However, correlation between specific 
physician or surgeon density and specific cancer mortality 
has been inconsistent. Main reasons for such inconsistence 
include not considering regional variations during analysis 
[4, 6, 15] and “plateau phenomenon” [6]. These reasons 
could also be applied to urologic cancers. 
Several recent studies have reported that there is no 
correlation between uneven distribution of urologists and 
mortality of bladder and prostate cancers [9, 10]. Fry et 
al. [9] have reported that urologist density is related to 
mortality rate of kidney and renal pelvis cancer, but not 
to that of bladder or prostate cancer. Yao et al. [10] have 
performed an updated ecological study using exploratory 
spatial analysis and found that there is an inconsistent 
relationship between urologist density and mortality rate 
of prostate cancer according to regional differences.
 In our study, although the total duration of 5 years 
was not long, doctor density and urologist density 
did not correlate with mortality rate of bladder cancer 
or prostate cancer. These results were obtained after 
considering difference in incidence of both cancers 
by year. The incidence of bladder cancer did not show 
significantly increasing pattern. However, the incidence 
of prostate cancer showed significantly increasing pattern 
in both metropolitan and non-metropolitan areas. For 
bladder cancer, there was an increasing pattern of cancer 
mortality in rural areas (Table 3). For prostate cancer, 
there was an increasing pattern of cancer mortality in 
both geographic areas. However, the increasing pattern 
was more prominent in non-metropolitan area (Table 3). 
These results provided valuable information that unevenly 
increasing patterns of cancer mortality in both cancers 
were not affected by uneven distributions of doctor density 
or urologist density. The phenomenon of a more prominent 
increasing pattern of cancer mortality could be explained 
by age factors. Although age standardization process 
was accomplished with ASMR1 and ASMR2, age was 
still a powerful impacting factor. Although mortality rate 
before age standardization was not shown in this study, 
there was a marked difference in mortality rates between 
metropolitan and non-metropolitan areas. In addition to 
age factor, there are other possible reasons for the non-
Table 2: Annual changes of doctor density and urologist density according to metropolitan and 
non-metropolitan areas
beta se Lower Upper p-value
Doctor
intercept 163.1 6.1 150.9 175.3 < 0.001*
area(non-metropolitan) –39.4 6.0 –51.3 –27.5 < 0.001*
year† 2.4 2.1 –1.7 6.6 0.249
Urologist
intercept 4.1 0.1 3.9 4.3 < 0.001*
area(non-metropolitan) –1.0 0.1 –1.2 –0.7 < 0.001*
year† 0.1 0.0 0.0 0.2 0.002*
†Year of 2007 was used as reference year.
*Statistically significant.
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correlation between urologist density and mortality rate of 
bladder cancer or prostate cancer.
 First, biological factors of each cancer might have 
contributed to such non-correlation. It is well-known that 
the general mortality rate dominates over prostate cancer 
specific mortality, especially in indolent prostate cancers. 
For bladder cancer, initial intensive treatment may not 
guarantee a more favorable survival outcome due to its 
Figure 2: Partial correlation analysis between cancer mortality rate or cancer incidence and doctor density or urologist 
density in bladder cancer.  
Table 3: Linear trend of incidence and mortality of bladder and prostate cancers
Estimate Std. Error p-value
Bladder
Metropolitan
ASMR1 year 0.137 0.060 0.028*
ASMR2 year 0.274 0.140 0.059
Incidence year 0.193 0.142 0.182
Non-metropolitan
ASMR1 year 0.145 0.046 0.003*
ASMR2 year 0.324 0.094 0.001*
Incidence year 0.124 0.140 0.378
Prostate
Metropolitan
ASMR1 year 0.045 0.057 0.437
ASMR2 year 0.022 0.096 0.820
Incidence year 13.077 4.414 0.006*
Non-metropolitan 
ASMR1 year 0.101 0.040 0.014*
ASMR2 year 0.178 0.065 0.009*
Incidence year 14.322 4.009 0.001*
*Statistically significant.
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biological feature of frequent recurrence [8]. Our results 
revealed that incidence and mortality of bladder cancer 
showed significant or borderline significant difference 
according to regional distribution. However, they showed 
no significant difference according to doctor density or 
urologist density. This suggests that biological factor of 
bladder cancer could be manifested differently according 
to circumstance. 
 Second, there are many confounding factors in 
determining a correlation between urologist density 
and bladder or prostate cancer mortality. Those factors 
consist of disease characteristics (tumor stage, tumor 
characteristics, and comorbidities) and socioeconomic 
factors (insurance status, annual income, education degree, 
and religion) [10]. Colli et al. [16] have reported that all 
cancer mortality is consistently correlated with income. 
Frye et al. [9] have also reported that uneven house income 
is an independent risk factor for mortality of kidney and 
bladder cancers. Clegg et al. [7] have shown that prostate 
cancer mortality is related to family income.
 Third, screening might have affected the non-
correlation. Urologists perform diagnostic and treatment 
processes. Hence, earlier detection of cancers due to 
higher urologist density in both metropolitan and non-
metropolitan areas might have produced better mortality 
outcome. Aneja et al. [13] have reported that radiation 
oncologists might have greater potential role than 
urologists because they are not involved in the screening 
process. However, their study also showed the limitation 
of plateau effect which provided marginal benefit. Such 
plateau effect has also been documented in other fields 
on doctor density [17, 18]. Mortality rate of urologic 
cancer could be decreased by earlier detection of cancer. 
However, this does not mean that patients with earlier 
detection are treated optimally due to higher urologist 
density with well-distribution.
 Fourth, the distance between rural area and 
metropolitan area or the distance between home and 
hospital call medical accessibility is also an impacting 
factor for cancer mortality. Moreover, medical expense in 
Korea is relatively low compared to that in other countries. 
Therefore, ‘plateau phenomenon’ from US or other 
western countries might need to be interpreted differently 
from this study. Moreover, as shown in our previous study 
[12], average urologist density in Korea is larger than 
that in US. In kidney cancers, a greater distance to a large 
volume hospital with available technical treatment such 
as partial nephrectomy is related to overall mortality [9]. 
Hence, distance to a metropolitan area where there are 
larger volume hospitals with more specialists is related to 
cancer mortality [19–21]. However, this could not be an 
issue in Korea because medical accessibility is excellent 
Figure 3: Partial correlation analysis between cancer mortality rate or cancer incidence and doctor density or urologist 
density in prostate cancer.
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due to developed transport system and relatively small 
distances. Such excellent medical accessibility might have 
resulted in the no-correlation between urologist density 
and mortality rates of bladder and prostate cancers.  
 Fifth, although it is a minor factor, difference in 
statistical method may play a role in inconsistent results 
among previous studies. All previous studies and the 
current study conducted linear or logistic regression 
models to investigate the relationship. However, Yao et al. 
[10] adopted geographically weighted regression model to 
control spatial non-stationarity in doctor residences.
 Finally, racial factor might have affected this non-
correlation. Most previous ecological studies about doctor 
supply and cancer mortality have been carried out in 
the US. This study is the first study carried out in Asia. 
Considering racial disparities including percentage of 
black people which might have affected prostate cancer 
mortality, our study might have also been affected by 
race factor. Therefore, results of this study need to be 
interpreted differently than those US studies. 
 Although this study is the first study in Asia, there 
remains several limitations. First, this study has a short 
duration for mortality outcome (from 2007 to 2011). 
However, this study approached mortality for all those 
years. It was not a cross-sectional study.
 Second, this study categorized metropolitan and 
non-metropolitan areas. This resulted in fewer county 
units than other categorizations such as metropolitan, 
general city, and rural areas [12]. However, previous 
studies had sampling limitations in that most of them did 
Table 4: Univariate analysis for cancer incidence, ASMR1, and ASMR2
Bladder cancer Prostate cancer
beta
95% CI
p-value beta
95% CI
p-value
Lower Upper Lower Upper
Incidence
Area (non-
metropolitan) 1.384 0.820 1.949 0.000* 8.283 –8.465 25.032 0.328
No. of training hospital –0.030 –0.071 0.010 0.143 1.617 0.612 2.623 0.002*
Doctor density –0.009 –0.019 0.000 0.055 0.085 –0.171 0.341 0.510
Urologist density –0.588 –1.050 –0.127 0.013* 4.219 –8.272 16.710 0.503
Income 0.000 –0.001 0.000 0.000* 0.001 –0.005 0.008 0.650
Temp –0.153 –0.398 0.092 0.217 –5.594 –11.918 0.730 0.082
ASMR1
Area (non-
metropolitan) –0.202 –0.409 0.005 0.056 –0.094 –0.283 0.095 0.324
No. of training hospital 0.000 –0.013 0.013 0.997 –0.001 –0.013 0.011 0.900
Doctor density 0.001 –0.002 0.005 0.397 0.001 –0.002 0.004 0.502
Urologist density 0.120 –0.035 0.276 0.126 0.040 –0.101 0.181 0.572
Income 0.000 0.000 0.000 0.248 0.000 0.000 0.000 0.700
Temp 0.019 –0.062 0.100 0.645 0.026 –0.046 0.099 0.473
Incidence –0.001 –0.076 0.073 0.976 0.001 –0.002 0.003 0.634
ASMR2
Area (non-
metropolitan) –0.438 –0.894 0.018 0.060 –0.117 –0.434 0.200 0.466
No. of training hospital –0.013 –0.043 0.016 0.368 –0.010 –0.030 0.010 0.343
Doctor density 0.001 –0.006 0.008 0.774 –0.001 –0.005 0.004 0.833
Urologist density 0.186 –0.158 0.530 0.285 –0.042 –0.278 0.195 0.726
Income 0.000 0.000 0.000 0.140 0.000 0.000 0.000 0.551
Temp 0.211 0.039 0.383 0.017* 0.081 –0.039 0.201 0.184
Incidence –0.025 –0.189 0.139 0.763 0.000 –0.004 0.004 0.924
p-value adjusted by year;
*Statistically significant.
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not include rural areas [6, 9]. It is important to include 
rare events in rural areas because the main focus of most 
ecological studies is to determine proper distribution of 
doctors and hospital volumes. Without excluding rural 
area, we categorized county units as metropolitan and non-
metropolitan areas. 
 Third, due to the nature of ecological studies, 
this study did not include individual characteristics or 
covariate data. Moreover, data were not generated by 
patient units. Therefore, characteristics of data were 
indirect. Hence, caution is needed when interpreting 
results from ecological studies.
 Lastly, although our study provides useful evidence 
to determine proper urologist density, more evidence is 
needed to incorporate Korea specific situations. Medical 
accessibility is relatively excellent in Korea owing to 
developed transportation and low medical expenses. This 
could be a rationale that Korea does not need the same 
urologist density as required by US. However, evaluating 
proper urologist density is not simple because we not only 
have to consider factors for providing optimal treatment 
for urologic cancers, but also have to consider factors 
involved in in screening and providing palliation treatment 
for urologic cancers. Future studies are warranted to 
examine the potential of urologist density on the entire 
quantity of urologic cancers from screening to mortality 
and examine the inter-relationship between urologist 
density and cancer mortality considering individual patient 
levels, health care resources, and sociodemographic 
components [10]. In addition, comparative ecological 
studies are needed regarding health services provided 
for urologic cancers after adjusting for individual social 
features in developing countries and developed countries.
In summary, an uneven distribution of doctors 
and urologists in metropolitan and non-metropolitan 
areas existed in Korea in the period of 2007 to 2011. A 
marked increase in mortality rate of bladder and prostate 
cancers was found in non-metropolitan areas during the 
analysis period. However, age standardized mortality rates 
of bladder and prostate cancer were not affected by the 
uneven distribution of doctors and urologists by years. 
Further studies are needed to demonstrate the adequacy 
of doctors and urologists to predict favorable prostate and 
bladder cancer mortality considering cost-effectiveness. 
MATERIALS AND METHODS
Study design
This was an ecological study using national 
representative data in Korea from 2007 to 2011. 
Metropolitan and non-metropolitan areas were geographic 
units for analysis. A total of 16 county units, including 
7 metropolitan units and 9 non-metropolitan units, were 
adopted to cover the absence of mortality rate information 
for rural areas. Moreover, our previous study has revealed 
that differences in doctor and urologist densities between 
metropolitan areas and non-metropolitan areas (non-
metropolitan cities or rural areas) are evident [12]. These 
16 county units are mainly based on the definition by 
public administration which establishes demographic, 
geographic, and environmental characteristics of country 
levels. The geographic unit of the country was defined as 
metropolitan area and non-metropolitan area established 
by the Ministry of Security and Public Administration. In 
Korea, the Ministry of Security and Public Administration 
currently lists a total of 163 county units at national 
level. However, we divided the total country into 16 
units (7 metropolitan cities and 9 non-metropolitan areas) 
because most rural areas did not have detailed mortality 
data. Moreover, some rural areas have been merged into 
general cities. According to the Ministry of Security and 
Public Administration, a metropolitan city was defined 
as county units with more than 1,000,000 population. 
Table 5: Multivariable analysis for incidence of bladder and prostate cancers
Bladder cancer Prostate cancer
beta
95% CI
p-value beta
95% CI
p-value
Lower Upper Lower Upper
Area (non-
metropolitan) 1.401 0.558 2.243 0.001
No. of training 
hospital 1.487 0.460 2.514 0.005
Doctor density
Urologist density 0.384 –0.216 0.985 0.206
Income 0.000 0.000 0.000 0.055
Temp –3.677 –9.865 2.512 0.240
p-value adjusted by year;
*Statistically significant.
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A non-metropolitan area was defined when the sum of 
county units has more than 50,000 in population and less 
than 50,000 in population in each county unit. Most of 
this study design and methods have been described in a 
previous report [12].
Definition of variables including doctor density, 
urologist density, and covariates
Numbers of doctors and urologists in each county 
unit were obtained from the National Health Insurance 
Service and the Ministry for Health, Welfare and Family 
Affairs. This is different from the US where the American 
Medical Association (AMA) Masterfile provides the 
number of physicians [22]. Urologist density was defined 
as the number of urologists per 100,000 individuals at 
county level. Doctor density was defined as the number of 
doctors per 100,000 individuals at county level. Doctors 
include all doctors who have certification as a medical 
doctor, including primary physicians and specialists. 
Population data was obtained from the Population Census 
Division, National Statistical Office of Korea. Total 
productivity sum of each county unit and individual 
income data were obtained from the Survey Management 
Bureau, National Statistical Office of Korea.
Local temperatures were obtained from the National 
Atmospheric Administration of Korea. South Korea is 
located in the southern portion of the Korean Peninsula, 
which extends about 1,100 km (680 mi) from the Asian 
mainland. The country, including all its islands, lies 
between latitudes of 33° and 39°N with longitudes 124° to 
130°E. Its total area is 100,188 square kilometers (http://
www.ngii.go.kr/kor/board/view.do?rbsIdx=103&idx=66). 
Local temperature was defined as the average temperature 
for one year including four distinct seasons: spring, 
summer, autumn, and winter.
Definition of incidence and mortality rate
Incidence rate was defined as age adjusted incidence 
rate (per 100,000) for both bladder and prostate cancers. 
For prostate cancer, only male data were used. Two 
forms of mortality rates were used in this study: observed 
mortality rate (per 100,000) for each county unit, and 
age standardized mortality rate (ASMR). The observed 
mortality rate was defined as the number of deaths per 
100,000 persons. ASMR was calculated with the following 
equation: ASMR = sum of (standard population in a specific 
age group × observed mortality rate in specific age group)/
sum of standard population in specific age group. We made 
two subsets of ASMR: ASMR1 and ASMR2. ASMR1 
was calculated by using age groups of 10–19, 20–29, 
30–39, 40–49, 50–59, 60–69, 70–79, 80–89, 90–99, and 
≥ 100. ASMR2 was calculated by using age groups of 
< 40, 40–49, 50–59, 60–69, 70–79, 80–89, and ≥ 90.
Main outcomes and statistical analysis
Basic characteristics of the two geographic groups, 
including annual incidence, mortality rate, doctor density, 
urologist density, number of teaching hospitals, annual 
average income, and annual average temperature were 
analyzed using t-test. Annual changes in doctor density 
and urologist density were analyzed using linear regression 
analysis. In this analysis, doctor density and urologist 
density were fitted to the model with fixed independent 
variables of county unit (area) after adjusting for years. 
Trends of incidence and mortality of bladder and prostate 
cancer were analyzed separately according to county 
unit using linear regression analysis. In this analysis, 
dependent variables were incidence of both cancers and 
ASMR1 and ASMR2 of both cancers. To estimate the 
role of doctor density and urologist density as risk factors, 
univariate analyses were performed with independent 
variables (including numbers of teaching hospitals, annual 
average income, and annual average temperature) and 
dependent variables (including incidence of both cancers 
and ASMR1 and ASMR2 of both cancers). The year was 
adjusted during these analyses. Multivariable analysis was 
conducted using significant independent factors identified 
from univariate analysis. 
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